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Abstract 
Introduction: the problem of neuroprotective or neurodegenerative effects of drugs for general 
anesthesia is relevant in connection with a large number of cases of postoperative cognitive 
dysfunction (POCD). 
Objectives: the aim of the study was to develop a goal-oriented combination of drugs for general 
anesthesia, based on a retrospective assessment of the baseline level of neurological and cognitive 
disorders in adults and children at the stage of preparation for surgery for neoplasms of the central 
nervous system (sub- and supratentorial neoplasms – SubTNN and SupraTNN), and a prospective 
evaluation of complications in the postoperative period. 
Methods: an experimental prospective multicenter open-label study. Criteria for including 
patients in the study. Patients over 5 years divided into subgroups of children (5-17 years) and 
adults (over 18 years), with neoplasms of the CNS, with indications for surgical treatment 
(operation: total or subtotal neoplasm removal). We examined 303 adult patients and 125 children 
who underwent surgery for CNS neoplasms of different localization. 
Results: а special feature in the initial assessment of the severity of patients with ICP tumor origin is 
the relationship not only with neurological deficits (GCS 11.0 ± 3.0 points, MMSE 23.0 ± 2.2 points, 
MRC 3.2 ± 1.1 points), but with multiple organ damage according to the SOFA scale (up to 4-5 
systems, with an estimate of 12.0 ± 3.5 points). The constant intraoperative risks associated with ICP 
syndrome include: a chance of developing hemodynamic instability in adults from 32.1 to 32.7% for 
SubTNN, in children up to 30% for SubTNN. Characteristics of the dynamics of neurospecific 
proteins were first isolated depending on the indicators of central and cerebral dynamics in children 
and adults with neoplasms of the central nervous system. Disturbance of cerebral hemodynamics and 
the presence of the main pathology (neoplasms of the posterior cranial fossa – PCF) in patients of the 
SubTNN group caused an increase in the value of the S-100 protein. The mean values were 0.239 ± 
0.13 μg/ml, Me = 0.179 (0.171-0.19) in adults and 0.251 ± 0.093, Me = 0.16 (0.12-0.2) in children, 
which was higher than normal. When assessing the degree of neuroregeneration by the level of the 
CNTF value, it was revealed that the mean values were significantly increased in the subgroups of 
adults and children, and amounted to 17.64 ± 7.92 pg/ml, Me = 11.63 (9.37-12.26) in adults, and 12.9 
± 0.71, Me = 11.35 (8.46-12.18) in children. In the SupraTNN group, the elevated levels of the 
average S-100 protein values up to 0.266 ± 0.043 μg/ml, Me = 0.148 (0.129-0.145) were found in 
adults, and up to 0.225 ± 0.04 μg/ml, Me = 0.135 (0.092-0.165) in children. The degree of 
neurodegenerative processes, due to the supratentorial neoplasm, was high in both children and adults. 
At the same time, mean values of the level of CNTF in this group were significantly higher than in all 
comparison groups and amounted to 27.09 ± 11.5 pg/ml, Me = 17.76 (14.55-20.7) in adults, and 26.24 
± 5.06 pg/ml, Me = 14.56 (12.04-15.84) in children. Multicomponent modifications of general 
anesthesia for patients with neoplasms of the central nervous system aimed at correction and 
Rus. 
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prevention of neuro-cognitive impairment by the influence on the links of the stress system have been 
developed. To stimulate the stress-limiting (SL) link, benzodiazepines, sodium oxybutyrate are used, 
barbiturates, inhalation anesthetics are used to stimulate the stress-limiting link and inhibit the stress-
activating (SA) link, ketamine is used to stimulate the stress-activating link, clonidine is used for 
simultaneous stimulation of the stress-activating and stress-limiting link, and fentanyl is used for 
simultaneous suppression of stress-activating and stress-limiting elements. 
Conclusion:  The revealed age-specific features of neuro-cognitive deficits in patients with 
neoplasms of the central nervous system indicate the need for an individual pharmacological 
approach to the combination of drugs for general anesthesia, with an aim to reduce postoperative 
deficits. 
Key words: pharmacological correction; neurosurgery; neoplasms; anesthesia; intensive therapy; 
postoperative cognitive dysfunction. 
Introduction. 
The problem of neuroprotective or 
neurodegenerative effects of drugs for general 
anesthesia is a conjunctural topic for most 
participants in the treatment support process (mainly 
for insurance companies). While for professionals 
who are directly involved in treatment, this problem 
is still unsolvable, so it is often tried to ignore it, 
under the cover of existing protocols and algorithms 
of anesthesia. Nevertheless, the problem exists. 
So, for example, there are interesting 
publications that children who have undergone 
anesthesia are violated ability to learn skills, 
cognitive functions. Some authors do not agree that 
the data obtained in animal experiments can be 
transferred to humans, and they state that there is no 
neurodegeneration from general anesthetics in 
children on the basis of magnetic resonance imaging 
[1]. R.T. Wilder et al. Studied 8548 pupils in the city 
of Rochester in Minnesota (USA) and found that 
children who had undergone several anesthesia 
before the age of four were more likely to register an 
inability to learn [2]. On the other hand, general 
anesthetics are used to protect the brain with various 
injuries of neurons: traumatic, ischemic-hypoxic, 
toxic. Improvement of protein synthesis, GABA-
ergic activity and antioxidant properties of propofol, 
barbiturates and NMDA antagonists can be the main 
mechanisms of their neuroprotective action [3, 4]. 
Thus, in some situations, the positive effect of 
general anesthetics on the brain, and in others – 
negative. Methods of preventing the neurotoxic effect 
of anesthesia have not yet been developed. Most 
often, for this purpose, preparations of the nootropic 
group are used, which improve the synthesis of 
nucleic acids in neurons, mediator exchange. 
Given the fact that current clinical studies have 
not clearly demonstrated a worsening of behavioral 
development, it is possible that more harm can be 
done if urgent surgical intervention is needed, and 
timely treatment is delayed due to concerns about the 
hypothetical effects of anesthesia on subsequent 
development. However, the best effort to take into 
account all risks should be welcomed. 
Thus, anesthesia itself can not be toxic, but the 
drugs that we use can have neurotoxicity features. 
Therefore, it is desirable to clearly separate the desired 
effects from toxic and clearly determine the desired 
dose and / or combination of drugs to reduce toxicity. It 
is also not advisable to extrapolate the results of studies 
from one drug to the whole group (from isoflurane to 
sevorane or from nitrous oxide to ketamine, and from 
one group of patients to another) [5, 6, 7]. 
In this context, taking into account the initial 
disturbances in the neurological and cognitive status, 
with the prediction of complications in the 
postoperative period, the development of methods for 
correcting the revealed and predicted disorders is 
topical. 
The development of delirium and cognitive 
disorders has been studied in a number of works by 
the authors [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 
19, 20, 21]. Disturbances of hemodynamics are the 
most unpredictable, but the most insidious pathology 
of the intranarkoznogo period, so it is possible to 
relate the percentage of postoperative cognitive 
disorders (POCD), up to the development of strokes. 
The authors revealed the relationship between the 
development of postoperative delirium with 
preoperative neurological status, hemoglobin level, 
patient age, natriuretic peptide, cerebral oximetry. 
Based on the results of the study and statistical 
analysis, it was concluded that it is the level of 
preoperative cerebral insufficiency that affects the 
development of postoperative cognitive impairment. 
It was revealed [22], that the frequency of 
postoperative delirium in adults is up to 4.7%, of the 
independent provoking factors, pre-operative 
administration of benzodiazepines, thoracic surgeries, 
abdominal cavity surgery and the duration of the 
operation were also isolated. It is known that new 
postoperative cognitive disorders account for up to 
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0.8% for planned surgery and up to 5.2% for urgent 
surgery. The risk of postoperative stroke increases in 
cardiovascular and neuro-vascular surgery, in 
patients with predisposing risk factors such as a 
previous stroke, carotid artery stenosis, open oval 
window, atrial fibrillation, infective endocarditis, 
diabetes mellitus, kidney failure, and advanced age 
[23, 24, 25]. In heart operations, POCD varies from 
28 to 100%, with extracardiac operations from 7 to 
26% [26]. 
Cognitive disorders in the elderly cause as much 
controversy as violations in children. However, 
available data suggest that POCD in elderly patients 
is diagnosed, as a rule, by local studies, rather than 
large-scale multicenter. The evaluation is based, as a 
rule, on subjective data of the patient or members of 
his family. Nevertheless, after even short surgical or 
diagnostic manipulations, up to 47% of patients 
demonstrate a decrease in cognitive function 24 
hours after anesthesia, at the time of discharge from 
31 to 47% and 3 months after surgery in 10% of 
patients [27, 28, 29]. However, there was no clear 
correlation with the type of anesthesia. As risk 
factors, elderly age, low educational level, duration 
of anesthesia and complexity of surgical intervention 
(vascular, orthopedic and heart surgery) were 
identified. 
However, no review discusses POCD after 
cerebral operations, although this is relevant [30, 31]. 
Objectives. 
The aim of the work was to assess the baseline 
level of neurological and cognitive disorders in adults 
and children at the stage of preparation for surgery 
for neoplasms of the central nervous system (sub- 
and supratentorial neoplasms) to predict 
complications in the postoperative period and the 
development on their basis of goal-oriented variants 
of anesthesia and intensive therapy. The main 
direction is pharmacological correction and 
prevention of cognitive and neurologic disorders in 
the half-operative period. 
Methods. 
Organization of basic research – experimental, 
prospective, multicenter, open-label study. Criteria 
for including patients in the study. Patients older than 
5 years divided into subgroups are children (5-17 
years) and adults (over 18 years), with neoplasms of 
the CNS, with indications for surgical treatment 
(operation: total or subtotal neoplasm removal). 
Criteria for exclusion from the study. Failure of 
surgery, critically ill patient (ASA V-VI). 
Patients and study groups. The research in 2003-
2009 was conducted in the Donetsk regional clinical 
territorial association: in the clinic of neurosurgery 
(the head of the clinic is d.med.n., Prof. Kardash 
AM), the department of neurosurgery intensive care 
unit (the head of the department is d.med.n., Prof. 
Gorodnik GA), department of anesthesiology (head 
of the department – Ph.D., Associate Professor 
Smirnova NN), and also in 2009-2015 in "Clinical 
Rudnichnaya Hospital", Makeevka: in the department 
anesthesiology and intensive care (head of the 
department – Ph.D., Associate Professor Kolesnikov 
AN), neurosurgery (the head of the department  Dr. 
Zhiharev DV). A total of 303 adults and 125 children 
who were operated on the central nervous system 
tumors of different localization (Table 1). 
Table 1 
Nosological forms of CNS involvement with ICP syndrome in the study groups 
Characteristic 
Subgroups 
Subtentorial 
Tumors 
(SubTNN) 
Supratentorial 
Tumors 
(SupraTNN) 
Study groups (adults, n = 303) 
amount 
Patients 
135 168 
Age, years (M±m) 50.6±8.4 37.8±5.2 
Sex (%) 
male 42.7 32.3 
Feminine 57.3 67.7 
Study groups (children, n = 125) 
amount 
Patients 
59 66 
Age, years (M±m) 13.9±4.4 12.9±2.3 
Sex (%) 
male 42.3 37.8 
Feminine 57.7 62.2 
Scales used in the study and description of 
groups. Patient history and complaints collection, 
including GCS scores, taking into account the need to 
assess neurological deficits, the modified Modified 
Rankin Scale (MRE) was used for adults and 
children, for the diagnosis of the degree of cognitive 
impairment, the scale "A Brief Scale of Mental Status 
Kolesnikov A.N., Gorodnik G.A., Grigorenko A.P., Mustafin T.A., Kolesnikov N.E., Koktishev I.V. The 
main directions for pharmacological correction (combinations of drugs for general anesthesia) of 
neurological and cognitive disorders in patients with neoplasms of the central nervous system. 
Research result: pharmacology and clinical pharmacology. Vol. 3, №2 (2017): 79-90. 
./.
82 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
Assessment – MMSE (MiniMental Score 
Examination)». 
Interpretation of MMSE results [32]: the result 
of the test is obtained by summing the results for 
each of the items. The maximum in this test can be 
30 points, which corresponds to the highest cognitive 
abilities. For the relative rate, the MMSE score was 
more than 26 points. An estimate of 21-25 points was 
taken for moderate cognitive impairment, and less 
than 20 for severe cognitive impairment. 
Rankin's modified scale (The Modified Rankin 
Scale, MRS) [32]: allows to objectify the dynamics 
of neurological symptoms and functional disorders. 
The uniqueness of this scale consists in the 
possibility of using it in both adults and children, as 
well as in the ability to assess neurological deficits 
not only after a stroke, but after any cerebral 
insufficiency. 
The Coma Scale Glasgow (The Glasgow Coma 
Scale, GCS) is a scale for assessing the degree of 
impairment of consciousness and comedians over 4 
years old and adults [32]: Evaluation of cerebral 
hemodynamics. The parameters of cerebral 
hemodynamics were studied both in the preoperative 
and intra- and postoperative periods [33, 34, 35]. In 
the preoperative period, ICP measurement by a direct 
method was performed in groups with supra- and 
subtentorial neoplasms – only in the absence of risk 
to the life of the patient (wedging). In most cases, the 
initial data was taken with intraoperative 
ventriculostomy (in the presence of indications). The 
postoperative ICP measurement was performed in the 
neurosurgery intensive care unit / IT department until 
the moment of transfer to the neurosurgical 
department. Intraoperatively, fluctuations in ICP at 
different stages of the operation were noted. 
Cerebral perfusion pressure (CPP) was 
calculated according to the formula [36]: 
CPP = MAP-ICP, where MAP – mean arterial 
pressure; ICP – intracranial pressure. 
Table 2 
Calculated indices of CPP for different age groups [36]: 
Age Value of the CPP 
Newborn от25 mm Hg. 
2-5 years 45-65 mm Hg. 
6-12 years 55-75 mm Hg. 
Adults Not less than 70 mm Hg. 
Laboratory methods of research. Studies 
evaluating the degree of neurodegeneration and 
neuroreparation (neurospecific proteins). 
Protein S-100 (glial) kit is designed to quantify 
the tumor marker of protein S-100B (S-100A1B + S-
100BB) in serum samples by the enzyme 
immunoassay [37], evaluating the degree of 
neurodegeneration. This method, Fujirebio S100 
EIA, is based on the use of two different types of 
monoclonal antibodies: biotinylated anti-S-100B, 
monoclonal antibody S-23 and monoclonal anti-S-
100B MAb S-53 antibody conjugated with 
horseradish peroxidase, specifically recognizing 
different epitopes The S-100B molecule. 
Ciliary neurotrophic factor (neurons and glia) 
(CNTF) [38], as a factor of neuroregeneration. The 
Human CNTF Kit Quantikine ELISA Kit is designed to 
quantify the human ciliary (glial) neurotrophic factor 
(CNTF) in supernatant samples of cell cultures, serum, 
plasma by enzyme immunoassay. Measuring range: 8-
2000 pg / ml. Analytical sensitivity: 8 pg / ml. 
Statistical processing of data. The obtained data 
were subjected to statistical processing using the 
program STATISTICA 6.0. The quantitative indices for 
the normality of the distribution were estimated using 
the Kolmogorov-Smirnov agreement criterion (with the 
Lillieforce correction) [39]. The quantitative indicators 
are presented in the form M ± sd, where M is the 
arithmetic mean, sd is the standard deviation, the 
median (Me), minimum and maximum values were also 
determined. Since the distribution law of the 
quantitative indicators studied differed from the normal 
one, the statistical significance of the differences was 
checked using the Kruskall-Wallis criterion (in the case 
of multiple independent samples). This criterion is 
intended to assess differences between three or more 
samples at the level of a feature and can be considered 
as a nonparametric analog of the method of dispersion 
single-factor analysis for unrelated samples. In the case 
of dependent populations, the Wilcoxon W-test was 
used [40]. To estimate the difference between groups, a 
method was used to calculate the frequency of deviation 
from the norm. For the indicators characterizing the 
qualitative characteristics, the absolute number and the 
relative frequency in percent (P%) with the 
representation error (m) were indicated, and 95% 
confidence interval (95% CI) of the relative value was 
also calculated. To test the statistical hypotheses about 
the differences in relative frequencies, proportions, and 
ratios in two independent samples, the Pearson χ2 
criterion (with the Yates correction), the 95% CI 
difference, and the Fisher * φ criterion (the Fisher 
angular conversion), which is designed to compare two 
samples On the frequency of occurrence of the effect 
(sign). Fisher's angular transformation makes it possible 
to assess the significance of the differences between the 
shares of two samples in which the effect (feature) is 
registered [41]. In evaluating the effectiveness of the 
modified anesthetic method, the absolute risk (absolute 
difference) difference (AR), relative risk (RR), chances 
and odds ratio (OR) were calculated [42]. In all 
statistical analysis procedures, the achieved significance 
level (p) was calculated, with the critical significance 
level being assumed to be 0.05. 
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Results.  
Patients with subtentorial neoplasms (SubTNN). In 
this group of patients, cognitive dysfunction (see Table 
3-4) of medium degree (MMSE 21-25 points) was 
revealed in 72 ± 2.9% of adults and 94 ± 2.9% of 
children. Severe cognitive impairment was inherent in 
10.0 ± 1.25% of adults and 5.1 ± 2.9% of children. 
When assessing the degree of neurological deficits (see 
Figure 1, Table 3-4) in the group of subtentorial 
neoplasms, it was revealed that both adult patients and 
children were characterized by a higher severity on the 
Rankin scale, mean values for adults were 3.26 ± 0.53, 
Me = 3.0 (3.0-4.0), for children 2.90 ± 0.71, Me = 3.0 
(2.0-3.0). An evaluation of the distribution of changes 
in age groups showed that 4 points were found in 30.4 ± 
4.0% of adults and in 20.3 ± 5.2% of children, 3 points 
in 65.2 ± 4.1% of adults and in 49 , 2 ± 6.5% of 
children; and 2 points in 4.4 ± 1.8% of adults and in 
30.5 ± 6.0% of children. 
Table 3 
Degree of neurological deficiency, cognitive deficiency and degree of disturbance of cerebral hemodynamics 
 in groups of adult abs./Р±m, в % (95% CI) 
Groups / 
coefficient 
Excesses 
From the norm 
Scale 
Rankin (MRS) 
Level of ICP 
Level of 
MAP 
CPP level 
SCale 
MMSE 
SubTNN Before (n=135) Before (n=135) 
Before 
(n=135) 
Before 
(n=135) 
Before (n=135) 
2 
6/4.4±1.8 
(1.0 – 7.9) 
46/34.1±3.9 
(21.2 – 36.5) 
10/7.4±0.7 - 
Backlog 
/ Violation 
Mental development 
4/0.7±0.7 
(4.0 – 9.2) 
3 
88/65.2±4.1 
(57.1 – 73.2) 
83/61.5±4.3 
(44.2 – 61.0) 
- - 
Medium 
Cognitive impairment 
97/72±2.9% 
(46.5 – 80.7) 
4 
41/30.4±4.0 
(22.6 – 38.1) 
6/4.4±1.8 
(1.0 – 7.9) 
- - 
severe cognitive 
Violations 
16/12±3.6 
(8.5 – 20.4) 
SupraTNN Before (n=168) Before (n=168) 
Before 
(n=168) 
Before 
(n=168) 
Before (n=168) 
2 
51/30.4±3.5 
(23.4 – 37.3) 
152/90.5±3.8 
(53.9 – 68.7) 
22/13.1±3.4 
8/4.8±1.6 
(1.5 – 8.0) 
Backlog 
/ Violation 
Mental development 
8/4.8±1.6 
(1.5 – 8.0) 
3 
117/69.6±3.5 
(62.7 – 76.6) 
6/3.6±1.4 
(0.8 – 6.4) 
- - 
Medium 
Cognitive impairment 
129/76.8±3.3 
(70.4 – 83.2) 
4 
0/0.6±0.6 
(0.0 – 1.7) 
- - 
severe cognitive 
Violations 
31/18.5±3.0 
(12.6 – 24.3) 
Table 4 
Degree of neurological deficiency, cognitive deficiency and degree of disturbance of cerebral hemodynamics 
 in groups of children abs./Р±m, в % (95% CI) 
Groups / 
coefficient 
Excesses 
From the norm 
Scale 
Rankin (MRS) 
Level of ICP 
Level of 
MAP 
CPP level 
Scale 
MMSE 
SubTNN Before (n=59) Before (n=59) 
Before 
(n=59) 
Before 
(n=59) 
Before (n=59) 
2 
18/30.5±6.0 
(18.8 – 42.3) 
8/13.5±3.9 
(2.5 – 17.9) 
2/3.4±2.4 
(0.0 – 8.0) 
- 
Backlog 
/ Violation 
Mental development 
0/1.6±1.6 
(0.0 – 4.8) 
3 
29/49.2±6.5 
(36.4 – 61.9) 
49/74±6.2 
(52.2 – 76.6) 
- - 
Medium 
Cognitive impairment 
55/93.2±3.3 
(86.8 – 99.6) 
4 
12/20.3±5.2 
(10.1 – 30.6) 
2/3.3±2.4 
(0.0 – 8.0) 
- - 
severe cognitive 
Violations 
4/6.8±3.3 
(0.4 – 13.2) 
SupraTNN Before (n=66) Before (n=66) 
Before 
(n=66) 
Before 
(n=66) 
Before (n=66) 
2 
16/24.2±5.3 
(13.9 – 34.6) 
58/87.9±5.7 
(58.6 – 80.8) 
3/4.5±2.6 
(0.0 – 9.6) 
4/6.1±2.9 
(0.3 – 11.8) 
Backlog 
/ Violation 
Mental development 
3/4.5±2.6 
(0.0 – 9.6) 
3 
43/65.2±5.9 
(53.7 – 76.6) 
5/7.6±3.3 
(1.2 – 14.0) 
- - 
Medium 
Cognitive impairment 
58/87.9±4.0 
(80.0 – 95.8) 
4 
7/10.6 – 3.8 
(3.2 – 18.0) 
- - 
severe cognitive 
Violations 
5/7.6±3.3 
(1.2 – 14.0) 
Kolesnikov A.N., Gorodnik G.A., Grigorenko A.P., Mustafin T.A., Kolesnikov N.E., Koktishev I.V. The 
main directions for pharmacological correction (combinations of drugs for general anesthesia) of 
neurological and cognitive disorders in patients with neoplasms of the central nervous system. 
Research result: pharmacology and clinical pharmacology. Vol. 3, №2 (2017): 79-90. 
84 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
The mean values for the GCS were different, 
compared to 12.76 ± 1.21, Me = 13.0 (12-14.0) in 
adults and 13.25 ± 1.36, Me = 14.0 (13.0-15.0) in 
children. When assessing the distribution according 
to the GCS, it was found that 41.5 ± 4.2% of adults 
and 20.3 ± 5.2% of children had 10-11 points; 11-12 
points 58.5 ± 4.2% of adults and 69.5 ± 6.0% of 
children; and only 10.2 ± 2.9% of children had 13-14 
points. 
The importance of determining the intragroup 
distribution by severity is evidenced precisely by this 
group of patients. So, clinically, children with a score 
of 4 on the Rankin scale and 10-11 points in the 
GCS, despite their small number (20%), were 
extremely difficult for an anesthesiologist, compared 
to even a similar group of adults (up to 40%). 
The revealed regularity was confirmed in the 
evaluation of cerebral hemodynamics (see Table 3-
4). The incidence of ICP in adults was significantly 
higher than in children, the mean values were 50.6 ± 
12.1, Me = 50.0 (38.6-62.7) in adults and 44.9 ± 8.7, 
Me = 44.0 (36.1-53.4) in children. Intra-group 
distribution of ICP change was characterized by a 
large spread of ICP indices. In terms of the severity 
of ICP, excess of up to 3.1-4.0 norms was found in 
4.4 ± 0.7% of adults and 5.3 ± 0.7% of children, 
exceeding to 2.6-3.0 norms – in 8.9 ± 1.4% of adults 
and 18.6 ± 3.6% of children; the excess to 2.1-2.5 
rates – in 52.6 ± 2.2% of adults and 64.4 ± 4.2% of 
children; up to 1,0-2,0 norms in 28,9 ± 3,5% of adults 
and 10,1 ± 1,5% of children. Thus, 83% of children 
and 61.5% of adults had high and extremely high 
rates of  ICP. 
The initial severity of patients in this group also 
characterized the average values of MAP (see Table 
3-4), which tend to be hypodynamic in the blood 
circulation. In adults, the MAP was 103.8 ± 13.2, Me 
= 100 (90.6-117), in children 71.25 ± 7.5, Me = 70.0 
(63.7-78.8). An evaluation of the intra-group 
distribution of MAP variation showed that a decrease 
in MAP to 0.3-0.5 norms was observed in 62.2 ± 
9.5% of adults and 33.9 ± 4.6% of children, a 
decrease to 0.7-0.8 Norms were found in 25.9 ± 3.7% 
of adults and 45.7 ± 7.5% of children. An increase to 
1.2-1.5 rates in 5.9 ± 0.7% of adults and 3.4 ± 1.9% 
of children. 
The received data, expectedly, were reflected in 
the indicators of the CPP (see Table 3-4). Mean 
values for adults were 53.7 ± 9.2, Me = 54.0 (52-
54.5) and 46.36 ± 6.7, Me = 40.0 (40.1-53.1) in 
children, which significantly differed from the norm 
and between themselves. Evaluation of the intra-
group change in the CPP showed no statistical 
difference between the dynamics of changes in age 
groups. Thus, a decrease in the CPP to 0.3-0.5 norms 
was found in 50.4 ± 8.5% of adults and 54.2 ± 5.7% 
of children. Subnormal (up to 0.7-0.8 norms) in 45.9 
± 3.3% of adults and 40.7 ± 7.9% of children. 
   а. b.  
Fig. 1. Abnormal mean values of GCS and MRS in adults and children in the SubTNN group 
(where 1 – values of normal indicators) 
The indices of the changes in the levels of 
neurospecific proteins are shown in Fig.2. Disturbance 
of cerebral hemodynamics and the presence of the main 
pathology (neoplasms of PCF) in patients of this group 
caused (see Fig. 2) an increase in the value of protein S-
100. The mean values were 0.239 ± 0.13, Me = 0.179 
(0.171-0.19) in adults and 0.251 ± 0.093, Me = 0.16 
(0.12-0.2) in children, which significantly exceeded the 
norm. The degree of excess of the normal indices of the 
S100 protein in this group was most pronounced by 
exceeding to 2 norms in 92.5 ± 3.8% of adults and 88.8 
± 6.8% of children. 
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а. b.  
Fig. 2. The deviation from the norm of the mean values of the indices of neurospecific proteins in adults and children in the 
SubTNN group (where 1 – values of normal indices) 
When assessing the degree of neuroregeneration 
by the level of the CNTF value, it was revealed that the 
mean values were significantly increased in both 
subgroups and were 17.64 ± 7.92, Me = 11.63 (9.37-
12.26) in adults and 12.9 ± 0.71, Me = 11.35 (8.46-
12.18) in children. Exceeding up to 4-7 norms was 
found in 22.5 ± 7.8% of adults and 38.2 ± 5.2% of 
children, an increase to 1-3 norms in 76.5 ± 8.2% of 
adults and 48.9 ± 1,9% of children. 
Thus, the high level of ICP, the desire for 
hypodynamia in the indices of central hemodynamics, 
and the disturbed CPP dictated the need to observe a 
"delicate balance" relative to the balance of the 
neuroregenerative and neurodegenerative processes of 
the central nervous system. 
Patients with supratentorial neoplasms 
(SupraTNN). Cognitive dysfunction (see Table 3-4) of 
moderate degree (MMSE 21-25 points) was diagnosed 
in 77 ± 5.5% of adults and 89 ± 2.5% of children.  
Evaluation of the neurological deficit (Figure 3, 
see t.3-4) on the Rankin scale characterized this group 
as severe. The mean indices did not differ from the 
group of SubTNN and amounted to 2.7 ± 0.46 points, 
Me = 3.0 (2.0-3.0) in adults and 2.86 ± 0.58 points, 
Me = 3.0 (3.0-3.0) in children. However, the 
distribution by severity among the patients of the study 
groups showed that only 10.6 ± 3.8% of children had 4 
points on the Rankin scale, 3 points had 69.5 ± 3.5% of 
adults and 65.2 ± 5.9% children; 2 points 50.4 ± 3.5% 
of adults and 24.2 ± 5.3% of children. 
а. b.  
Fig. 3. Abnormal mean values of GCS and MRS in adults and children in the group of SupraTNN 
 (where 1 – values of normal indicators) 
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The average data from the GCS indicated that in 
adults this score was 14.05 ± 0.92 points, Me = 14.0 
(13.0-15.0), in children – 14.21 ± 0.81 points, Me = 
14.0 (14.0-15.0). Intra-group distribution was: 13-14 
GCS points in 39.9 ± 3.8% of adults and 40.9 ± 6.1% of 
children; 11-12 points in 55.4 ± 9.8% of adults and 54.5 
± 6.1% of children and depending on the volume of 
neoplasm up to 4.8 ± 1.6% of adults and 4.5 ± 2.4 
children had disorders of consciousness at the level of 
sopor (10-11 points of the GCS). 
The average values of the ICP level (see tables 
3-4) were 28.3 ± 6.6 mm Hg.,  Me = 28.0 in adults and 
35.6 ± 7.1 mm Hg., Me = 35 (28.5-42.7) in children. 
The severity of ICP, also significantly different from the 
groups SubTNN. So an increase in ICP to 2.6-3.0 
norms was diagnosed only in 3.5 ± 1.2% of adults and 
7.5 ± 1.2% of children, an increase in ICP to 1.6-2.0 in 
61 , 3 ± 6.4% of adults and 69.7 ± 5.8% of children, and 
an increase to 1.2-1.5 rates in 29.2 ± 2.1% of adults and 
18.2 ± 2.1% of children . 
The mean values of MAP (see Tables 3-4) tended 
to hyperdynamia (apparently compensatory) and 
significantly exceeded the indices in the previous study 
groups, and amounted to: adults – 113.4 ± 18.7 mm 
Hg., Me = 110.0 (94.7-132) mm Hg.. Children – 78.35 
± 5.38 mm Hg., Me = 78 (73-83.7) mm Hg.. 
Nevertheless, when assessing the group distribution, it 
was found that 3.6 ± 2.2% of adults and 7.6 ± 3.4% of 
children had a tendency to reduce MAP to 0.3-0.5 
norms, and 19,05 ± 9,3% of adults and 30,3 ± 6,5% of 
children decrease to 0,7-0,8 norms. Compensatory 
increase in MAP to 1.2-1.5 norms was observed in 11.9 
± 3.4% of adults and only in 4.5 ± 1.2% of children. 
The main mass (64.3 ± 4.4% of adults and 57.6 ± 8.6% 
of children) was normal MAP. 
The absence of a pronounced (acute, 
decompensated) hydrocephalic syndrome, explained the 
normal values of the CPP (see Tables 3-4). The mean 
values were as follows: adults 85.3 ± 5.1 mm Hg., 
Me = 85.0 (73-85) mm Hg.. children 52.3 ± 5.2 mm 
Hg., Me = 36.0 (50.5-57.7). Normal values of CPP 
were revealed in 51.8 ± 11.9% of adults and 42.4 ± 
9.7% of children. Subnormal (decrease to 0.7-0.8 
norms) in 43.5 ± 12.2% of adults and 51.5 ± 5.9% of 
children. 
The indices of the changes in the levels of 
neurospecific proteins are shown in Fig.4. 
The existing CNS neoplasm in this group was 
manifested by an elevated level of average values of the 
S-100 protein to 0.266 ± 0.043 μg / ml, Me = 0.148 
(0.129-0.145) in adults and up to 0.225 ± 0.04 μg / ml, 
Me = 0.135 (0.092- 0.165) in children. The degree of 
neurodegenerative processes, due to the supratentorial 
neoplasm, was high in both children and adults. 
Exceeding the level of protein S-100 to 1-2 norms was 
diagnosed in 76.3 ± 5.2% of adults and 92.5 ± 3.8% of 
children. 
The mean values of the level of CNTF in this 
group were significantly higher than in all comparison 
groups and amounted to 27.09 ± 11.5 pg / ml, Me = 
17.76 (14.55-20.7) in adults and 26, 24 ± 5.06 pg / ml, 
Me = 14.56 (12.04-15.84) in children. At the same time, 
an increase in the level of CNTF to 4-7 norms was 
revealed in 67.4 ± 7.2% of adult patients and 74.3 ± 
5.2% of children, an increase to 1-3 in 32.6 ± 8.7 % Of 
adults and in 16.9 ± 7.7% of children. 
а. b.  
Fig. 4. Deviation from the norm of the average values of the indices of neurospecific proteins in adults and children 
in the group SupraTNN (where 1 – values of normal indicators) 
Apparently, if the degree of neurodegeneration 
depends on the activity (prevalence) of the tumor 
process, neuroregeneration is based on the degree of 
manifestation of  ICP and the preservation of 
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autoregulation of the cerebral blood flow. 
For patients in this group, preservation of 
autoregulation of cerebral circulation and maintenance 
of stable indices of central hemodynamics were of 
priority for maintaining a positive trend towards the 
progression of neuroreparative processes. The risk 
group for "disrupting" compensation was up to 30% of 
children with unstable hemodynamics. 
In view of the revealed changes, the neuro-
cognitive status (GCS, MMSE, MRS), goal-oriented 
variants of multicomponent anesthesia (Table 5) were 
developed, including additional components of 
premedication, introductory and basic anesthesia, taking 
into account the effects on the links of the stress system 
with the aim of reducing Postoperative neuro-cognitive 
disorders. To stimulate the selective stress-limiting (SL) 
link, it is possible to use benzodiazepines, sodium 
oxybutyrate, barbiturates, inhalation anesthetics can be 
used to stimulate the SL-link and inhibit the stress-
activating (SA) link, to use the ketamine, simultaneous 
stimulation of SA- and SL-links – use clonidine  and for 
simultaneous inhibition of SA- and SL-units – fentanyl.
Table 5 
The main directions of the multicomponent modification anesthesia in patients with neoplasms of the central nervous 
system 
Group The necessary impact and effectiveness of the application of MM 
SubTNN 
adults 
It is necessary to strengthen activation of the SA-link, maximum stimulation of the SL-link. Basis anesthesia 
(total intravenous anesthesia as an "anesthetic of choice"): fentanyl 0.005% -1-1.5 μg / kg / h, ketamine 0.5% 
0.05-1.0 mg / kg / h (with reduction Of the total dose to 125 mg), sodium oxybutyrate 20-50 mg / kg / h, 
clonidine 0.01% 0.5-1.5 μg / kg / h. 
SubTNN 
children 
It is necessary to strengthen activation of the SA-link, maximum stimulation of the SL-link. Basis anesthesia 
(total intravenous anesthesia as an "anesthetic of choice") fentanyl 0.005% - 1.0 mcg / kg / h, ketamine 0.5% - 
0.05-1.0 mg / kg / h (with total dose reduction up to 125 mg), sodium oxybutyrate 20-50 mg / kg / h, propofol 
1% - 1-1.5 mg / kg / h. 
SupraTNN 
adults 
It is necessary to increase the activity of the SL-link (sodium oxybutyrate 10-20 μ / kg / hour (or 
benzodiazepines 0.5 mg / kg (0.02 mg / kg / h), clonidine 0.5-1.5 μg / kg / h , Fentanyl 1-1.5 μg / kg / h). 
SupraTNN 
children 
In view of the revealed changes in the parameters 
of the central (SBP) and cerebral (CPP) hemodynamics, 
modifications of pre- and intraoperative intensive 
therapy were performed (Table 6).
Table 6 
The main directions of intensive modification therapy in patients with neoplasms of the central nervous system 
Group The necessary impact and effectiveness of the application of MM 
SubTNN 
adults 
"Method of early detection of pathological reactions of the brainstem during removal of tumors of the posterior 
cranial fossa in children" (Pat. 46955): the basis of the declared model was the detection of "episodes of 
tachyarrhythmia" with fluctuations of BIS (from 30 to 60) during removal of the tumor of the PCF. In case of 
detection of ischemia of the trunk, the tactics of surgical intervention changed with the subsequent introduction of 
clonidine (0.5-1.5 μg / kg) ("Method of correction of pathological reactions of the brainstem when removing tumors 
of the posterior cranial fossa in children" - Pat. 47739). Chance of postoperative cerebral ischemia development in 
adults is 62.8%, in children - 30.0%. 
SubTNN 
children 
SupraTNN 
adults 
Stabilization of the parameters of the cardiovascular system at the level of moderate hyperdynamics, the need for 
antibiotic therapy; Method of correction of increased intracranial pressure. Chance of postoperative cerebral ischemia 
development in adults at 14.3%, in children - 12.4%. SupraTNN 
children 
Conclusion. 
1. Initial detection of neurological and cognitive
deficits in patients allows predicting the development of 
neuro-cognitive dysfunction in the postoperative period. 
In this case, the basis of therapeutic perioperative 
effects are mild to moderate disorders, for which a 
reversible process is possible. Neurological (MRS 4 
points) and cognitive (MMSE less than 20 points) of 
severe severity are irreversible and constitute permanent 
risks of postoperative complications. 
2. For patients with subtentorial neoplasms, a
high level of ICP, a decrease in the parameters of 
central hemodynamics and an impaired CPP dictates 
the need to observe the "delicate balance" of the 
balance of neuroregenerative and neurodegenerative 
processes of the central nervous system. 
Kolesnikov A.N., Gorodnik G.A., Grigorenko A.P., Mustafin T.A., Kolesnikov N.E., Koktishev I.V. The 
main directions for pharmacological correction (combinations of drugs for general anesthesia) of 
neurological and cognitive disorders in patients with neoplasms of the central nervous system. 
Research result: pharmacology and clinical pharmacology. Vol. 3, №2 (2017): 79-90. 
./.
88 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
3. For patients of the group with supratentorial
neoplasms, preservation of autoregulation of cerebral 
circulation and maintenance of stable indices of 
central hemodynamics in order to maintain a positive 
trend towards the progression of neuro-reparative 
processes is a priority. The group of risk for "failure" 
of compensation is up to 30% of children with 
unstable hemodynamics. 
4. Multi-component modifications of general
anesthesia for patients with CNS neoplasms (not 
excluding baseline analgesic component) have been 
developed. To stimulate the stress-limiting link – 
benzodiazepines, sodium oxybutyrate are used, 
barbiturates, inhalation anesthetics are used to 
stimulate the stress-limiting link and inhibit the 
stress-activating link, ketamine is used to stimulate 
the stress-activating link, simultaneous stimulation of 
the stress-activating and stress-limiting link – use 
clonidine and for simultaneous suppression of stress-
activating and stress-limiting elements – fentanyl. 
5. The goal-oriented strategy of anesthesia and
intensive care will solve the problem of improving 
the quality of anesthesia in patients with neoplasms 
of the central nervous system by reducing the 
chances of developing intra- and postoperative 
complications. 
6. The OR of development of postoperative
ischemic brain disorders (reduction of CPP) are: in 
adults from 13 to 62.8% for all nosological groups, in 
children from 5 to 30%. 
7. The use of modified methods of anesthesia
and intensive care will reduce the risk of cerebral 
ischemia (lower CPP in the postoperative period): in 
adults 40.2 times for SubTNN and 3.0 times for 
SupraTNN.  In children 6.6 times for SubTNN. 
8. In the postoperative period, the developed
methods of anesthesia and IT will have advantages in 
influencing the indicators of systemic and cerebral 
hemodynamics and will allow to achieve a reduction 
in the risk of development of cognitive dysfunction 
of average degree in 1.1-3.8 times in adults and in 
1.4-3.9 in children, will reduce the degree of 
neurological deficits (according to the MRS scale): in 
adults and children. 
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